SUBSCRIBE
SUBSCRIBE

Strategic Research Institute Release: Medicare Part D: Ramifications For The Pharmaceutical Industry At The Corporate & Product Levels Conference To Take Place April 25-26, 2005 In Washington, DC

October 19, 2005 | 
2 min read

WASHINGTON, Jan. 21 /PRNewswire/ -- A high-level executive industry conference titled "Medicare Part D: Ramifications for the Pharmaceutical Industry at the Corporate and Product Levels" organized by Strategic Research Institute in association with Campbell Alliance is scheduled to take place April 25-26, 2005 at the Westin Grand Hotel in Washington D.C. Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industries.

The two day intensive information and networking event features senior- level executives from major pharmaceutical and biotech companies, managed care organizations, pharmacy benefits managers (PBMs), and other related healthcare organizations. Presenters and panelists will discuss how the implementation of Medicare Part D will impact the pharmaceutical industry, as well as strategies for dealing with its effects.

The conference agenda will feature a variety of case study presentations, panel discussions and keynotes. Some of the topics covered include:

  -- Impact of Part D Regions on Pharmaceutical Companies' Commercial
     Managed Care Business

  -- The Impact of Medicare Part D on State Medicaid Programs

  -- The Evolving Role of Health Economics and Outcomes Research Under
     Part D

  -- Implications for Pharmaceutical Field Sales

  -- Impact of the MMA on Interactions Between Account Managers and Managed
     Care Customers

  -- Compliance and Persistence in the Medicare Population

  -- Looking Down the Road: the Impact of Medicare Part D on Clinical
     Development Efforts

  -- Potential Impact of ePrescribing

  -- Key Strategies for Communicating with the Senior Market

  -- Market Research Needs in a New Competitive Landscape

  -- The Shifting Role of PBMs

  -- Segmentation of the Senior Market and Implications for Pharmaceutical
     Companies

  -- Physician Prescribing Habits

  -- The Future of Medicare: Possible Changes on the Horizon and How
     Pharmaceutical Companies Can Prepare

To become a speaker or to submit your proposal, please contact Mark Alexay of Strategic Research Institute at malexay@srinstitute.com or call 212.967.0095, ext 251.

For more information on how to become a conference sponsor or exhibitor, please contact Mark Alexay at malexay@srinstitute.com or call 212.967.0095, ext. 251

For more information on how to become a media partner, please contact Cheryl Kahan-Radhuber at ckahan-radhuber@srinstitute.com or call 212.967.0095, ext. 273

Strategic Research Institute

CONTACT: Mark Alexay, +1-212-967-0095, ext. 251,malexay@srinstitute.com, or Cheryl Kahan-Radhuber, +1-212-967-0095, ext. 273,ckahan-radhuber@srinstitute.com, both of Strategic Research Institute